PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
48.35
-0.35 (-0.72%)
At close: Aug 15, 2025, 2:56 PM
PTC Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.76B | 1.77B | 806.78M | 900.66M | 900.45M | 927.56M | 937.82M | 798.18M | 818.73M | 770.45M | 698.8M | 696.62M | 618.23M | 569.38M | 538.59M | 492.23M | 471.89M | 430.45M |
Cost of Revenue | 1.08M | 3.99M | 57.4M | 201.8M | 200.45M | 194.79M | 142.66M | 47.26M | 51.78M | 48.69M | 44.68M | 43.11M | 35.64M | 33.36M | 32.33M | 27.89M | 26.02M | 23.96M |
Gross Profit | 1.76B | 1.77B | 749.38M | 698.86M | 700.01M | 732.77M | 795.16M | 750.92M | 766.95M | 721.76M | 654.12M | 653.5M | 582.59M | 536.02M | 506.26M | 464.34M | 445.87M | 406.49M |
Operating Income | 718.37M | 719.97M | -295.81M | -130.3M | -193.95M | -370.14M | -439.8M | -643.26M | -598.59M | -496.61M | -467.91M | -352.3M | -371.89M | -362.82M | -374.45M | -386.09M | -348.15M | -436.93M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 666.09M | 651.4M | -363.12M | -425.47M | -494.07M | -645.82M | -696.11M | -728.75M | -689.37M | -600.59M | -587.49M | -536.4M | -542.85M | -512.04M | -518.34M | -441.45M | -355.2M | -418.66M |
Net Income | 629.17M | 594.84M | -363.3M | -453.2M | -479.52M | -579.22M | -626.6M | -641.7M | -618.05M | -571.25M | -559.02M | -531.39M | -555.7M | -521.99M | -523.9M | -454.99M | -391.06M | -454.12M |
Selling & General & Admin | 324.36M | 308.6M | 300.91M | 292.52M | 299.95M | 318.9M | 332.54M | 348.97M | 348.2M | 339.64M | 326M | 319.83M | 308.96M | 297.95M | 285.77M | 274.68M | 263.27M | 248.05M |
Research & Development | 508.14M | 527.32M | 534.48M | 531.06M | 533.86M | 587.57M | 666.56M | 733.9M | 735.15M | 706.54M | 651.5M | 612.65M | 578.03M | 546.25M | 540.68M | 508.85M | 471.01M | 522.05M |
Other Expenses | 33.71M | 33.71M | 30.64M | 5.58M | 60.15M | 61.63M | 101.04M | 176.49M | 147.37M | 172.18M | 120.91M | 14.09M | -35.72M | -58.84M | -57.87M | 32.45M | 80M | 88.14M |
Operating Expenses | 866.22M | 869.63M | 866.03M | 829.16M | 893.96M | 1.01B | 1.15B | 1.31B | 1.28B | 1.22B | 1.13B | 1.03B | 967.48M | 911.14M | 881.21M | 832.53M | 778.52M | 810.32M |
Interest Expense | 147.12M | 160.25M | 166.99M | 170.21M | 156.76M | 142.68M | 129.18M | 109.41M | 102.13M | 94.69M | 90.87M | 88.87M | 89.79M | 90.38M | 86.02M | 87.81M | 87.05M | 69.87M |
Selling & Marketing Expenses | n/a | n/a | n/a | -4.59M | -4.59M | -4.59M | -4.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.25M | 17.25M | 17.25M |
Cost & Expenses | 1.05B | 1.06B | 1.11B | 1.04B | 1.1B | 1.21B | 1.29B | 1.35B | 1.33B | 1.27B | 1.18B | 1.07B | 1B | 944.5M | 913.54M | 860.42M | 804.53M | 834.28M |
Income Tax Expense | 36.91M | 56.56M | 176K | 27.73M | -14.55M | -66.59M | -69.51M | -87.05M | -71.32M | -29.34M | -28.47M | -5.01M | 12.85M | 9.94M | 5.56M | 13.54M | 35.86M | 35.46M |
Shares Outstanding (Basic) | 78.15M | 78.12M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.45M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
Shares Outstanding (Diluted) | 78.15M | 86.39M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.65M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
EPS (Basic) | 8.02 | 7.56 | -4.73 | -5.94 | -6.31 | -7.68 | -8.36 | -8.65 | -8.42 | -7.89 | -7.79 | -7.47 | -7.83 | -7.38 | -7.43 | -6.48 | -5.62 | -6.72 |
EPS (Diluted) | 6.97 | 6.51 | -4.73 | -5.94 | -6.31 | -7.68 | -8.36 | -8.65 | -8.42 | -7.89 | -7.79 | -7.47 | -7.83 | -7.38 | -7.43 | -6.48 | -5.62 | -6.72 |
EBITDA | 838.5M | 838.23M | -120.46M | -105.66M | -129.66M | -248.76M | -322.18M | -416.44M | -411.19M | -352.01M | -360.28M | -329.37M | -353.99M | -337.33M | -365.32M | -293.13M | -212.7M | -299.96M |
EBIT | 813.21M | 811.66M | -196.13M | -255.26M | -337.31M | -503.13M | -566.93M | -619.35M | -587.24M | -505.9M | -496.62M | -447.53M | -453.06M | -421.66M | -432.32M | -353.64M | -268.15M | -348.79M |
Depreciation & Amortization | 28.05M | 27.49M | 75.66M | 149.6M | 207.66M | 254.37M | 244.75M | 202.91M | 176.06M | 153.89M | 136.34M | 118.16M | 99.07M | 84.34M | 71.52M | 63.24M | 56.45M | 91.04M |